Avance Solo NPWT System - Negative-pressure wound therapy system, battery-powered, single-use
Access comprehensive regulatory information for Avance Solo NPWT System - Negative-pressure wound therapy system, battery-powered, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Molnlycke Health Care Pty Ltd, manufactured by Molnlycke Health Care AB in Sweden. The device registration started on October 06, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Avance® Solo Sets are part of Avance Solo Negative Pressure Wound Therapy System. It consists of Pump and Canister. Avance® Solo NPWT System is indicated for removal of low to moderate amounts of exudates from chronic, acute, traumatic, subacute and dehisced wounds, ulcers (such as diabetic, venous or pressure), surgically closed incisions, flaps, and grafts.